The effect of rituximab adjuvant GDP regimen on non-Hodgkin lymphoma and its influence on TK-1, FASL and PDGF-BB
| Just accepted | Online first | Issue | Totals | |
|---|---|---|---|---|
| HTML pages views | 0 | 0 | 30 | 30 |
| PDF downloads | 0 | 0 | 9 | 9 |
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.
|